Sirtex (Australia)
Sirtex Medical Limited is a medical device firm that offers radioactive treatment for inoperable liver cancer called SIR-Spheres microspheres. Sirtex was founded in 1997 in Australia and today has offices and production facilities in the U.S., Australia, Germany, and Singapore. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Sirtex (Australia), Australia, covering academic research published from 2002 to 2024. Read More.
Open Access Percentage
46%
Total
Publications
92
Total Open
Publications
42
Total
Citations
10K
Open Access
Percentage
46%
Total
Publications
92
Total Open
Publications
42
Total
Citations
10K
Breakdown
Publisher Open
24%
Both
20%
Other Platform Open
3%
Closed
53%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 45%
19
Hybrid 43%
18
No Guarantees 12%
5
Other Platform Open
Domain 77%
17
Other Internet 55%
12
Institution 36%
8
Preprint 0%
0
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 16 |
DOI | Other Internet | 12 |
University of Melbourne | Institution | 2 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 2 |
Université Libre de Bruxelles | Institution | 1 |
University of Hong Kong | Institution | 1 |
uniroma1.it OAI-PMH Repository | Institution | 1 |
Royal Netherlands Academy of Arts and Sciences | Institution | 1 |
Monash University | Institution | 1 |
King's College London | Institution | 1 |